NCT05289934 Effects of Recorded Music on Clinical and EEG Seizure Activity
| NCT ID | NCT05289934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2023-04-22 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2023-04-22 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is being done to determine if Mozart music and/or age-appropriate music can reduce the frequency of seizures and epileptiform discharges.
Eligibility Criteria
Inclusion Criteria: * Children (age: 4 - 17 years old) who stay at Epilepsy Monitoring Units (EMU) up to 7 days may join. Exclusion Criteria: * Non-English Speaking
Contact & Investigator
Sarah Kelley, MD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT05289934 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 17 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05289934 currently recruiting?
Yes, NCT05289934 is actively recruiting participants. Contact the research team at saminof1@jhmi.edu for enrollment information.
Where is the NCT05289934 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT05289934 clinical trial?
NCT05289934 is sponsored by Johns Hopkins University. The principal investigator is Sarah Kelley, MD at Johns Hopkins University. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.